Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Generative A.I. Designs Novel Synthetic Proteins

Human machine interface

Generate:Biomedicines describes its Chroma generative A.I. model in yesterday’s issue of the journal Nature, and is making the model available as open source through GitHub. . . . → Read More: Generative A.I. Designs Novel Synthetic Proteins

Cannabinoid Shown Safe, Lowers Agitation in Alzheimer’s Patients

Cannabis plant

A clinical trial in a small group of participants suggests a cannabinoid drug is safe and well-tolerated, and reduces agitation among patients with Alzheimer’s disease. . . . → Read More: Cannabinoid Shown Safe, Lowers Agitation in Alzheimer’s Patients

Start-Up Developing Precision Antibiotics for Resistant Bacteria

Pseudomonas Aeruginosa bacteria

A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds. . . . → Read More: Start-Up Developing Precision Antibiotics for Resistant Bacteria

Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Adeno-associated virus

A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round. . . . → Read More: Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Peanut Allergy Toothpaste Shown Safe in Trial

A woman brushing her teeth

Results of a clinical trial show a peanut allergy treatment formulated as a toothpaste can safely deliver immunotherapy to raise recipients’ peanut tolerance. . . . → Read More: Peanut Allergy Toothpaste Shown Safe in Trial

Challenge Seeks Transformative Human/A.I. Research Tech

Illustration: Artificial intelligence with a human face

A new challenge competition with $1 million in prizes seeks novel techniques for conducting biomedical research with data on human physiology and artificial intelligence. . . . → Read More: Challenge Seeks Transformative Human/A.I. Research Tech

Home V.R. Therapy Shown to Reduce Back Pain

Man in pain holding lower back

A virtual reality program conducted at home is shown in a clinical trial to relieve chronic lower back pain intensity and improve daily living more than a sham V.R. program. . . . → Read More: Home V.R. Therapy Shown to Reduce Back Pain

Electric Pulses Induce Lung Cancer Immune Response

Lung cancer illustration

Results of a clinical trial show a lung cancer therapy using highly focused pulses with electrical energy show signs of immune responses that can treat the patients’ tumors. . . . → Read More: Electric Pulses Induce Lung Cancer Immune Response

Merger to Form Programmable Nano-Medicines Company

Molecule model in an open hand

A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties. . . . → Read More: Merger to Form Programmable Nano-Medicines Company

Organ Chip Devices to Model for Radiation Sickness

Organ on a chip

The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness. . . . → Read More: Organ Chip Devices to Model for Radiation Sickness